⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15044813 | 0.84 | — | — | |
| SCHEMBL14005675 | 0.84 | — | — | |
| SCHEMBL23719059 | 0.75 | — | — | |
| SCHEMBL32680463 | 0.68 | — | — | |
| SCHEMBL1618015 | 0.68 | — | — | |
| SCHEMBL409447 | 0.68 | — | — | |
| SCHEMBL12122527 | 0.64 | — | — | |
| SCHEMBL13742846 | 0.64 | — | — | |
| SCHEMBL18950143 | 0.64 | — | — | |
| SCHEMBL12678154 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11813278-B2 | Highly active compounds against COVID-19 | Atea Pharmaceuticals, Inc. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20170131204-A1 | OPTICAL SENSORS USING SURFACE PLASMON RESONANCE TO DETERMINE AT LEAST ONE PROPERTY RELATING TO PHASE CHANGE OF A HYDROCARBON-BASED ANALYTE | SCHLUMBERGER TECHNOLOGY CORPORATION | 2017-05-11 | — | — | US | disclosed |
| US-20170029469-A1 | CYCLOSPORIN ANALOGS | ALLERGAN, INC. | 2017-02-02 | — | — | US | disclosed |
| US-9493511-B2 | Cyclosporin analogs | ALLERGAN, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| US-20150065433-A1 | CYCLOSPORIN ANALOGS | ALLERGAN, INC. (US) | 2015-03-05 | — | — | US | disclosed |
| EP-2321128-B1 | HALFTONE PRINTING OF METAL-PIGMENTED INKS TO PRODUCE VARIOUS METALLIC APPEARANCES | SUN CHEMICAL CORP (US) | 2014-02-12 | — | — | EP | disclosed |
| US-20120295856-A1 | FREDERICAMYCIN DERIVATIVES | ZENTOPHARM GMBH (DE) | 2012-11-22 | — | — | US | disclosed |
| US-20120088734-A1 | Cyclosporin Analogs | ALLERGAN, INC. (US) | 2012-04-12 | — | — | US | disclosed |
| US-20110230372-A1 | GENE EXPRESSION CLASSIFIERS FOR RELAPSE FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE IMPROVE RISK CLASSIFICATION AND OUTCOME PREDICTION IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA | STC UNM | 2011-09-22 | — | — | US | disclosed |